Meizhong Jin

Meizhong Jin

Company: AstraZeneca

Job title: Senior Director of Oncology Chemistry


What Can Emerging Induced Proximity Modalities Learn from TPD’s Journey to Accelerate Their Development 9:05 am

Targeted protein degradation (TPD) has been the most advanced induced proximity modality for the last decade. As the first and most advanced modality, TPD’s journey from an academic idea to proof-of-concept to the clinic has many valuable learnings for other emerging modalities in the induced proximity field. This workshop will seek to leverage the experience…Read more

day: Workshop A

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.